Abstract:Background: Keratinocytes participate in initiation and amplification of T-cell-mediated skin diseases. During these disorders, histamine can be released from both residents skin cells and immigrating leukocytes, and can affect the functions of dendritic cells, monocytes, and lymphocytes. Little information is available on the effects of histamine on keratinocytes. Objective: To examine the presence of functional H1 receptors on human keratinocytes and the capacity of histamine to modulate the expression of inflammatory molecules in these cells. Methods: Primary cultures of resting and cytokine-activated keratinocytes from healthy subjects were analyzed for histamine H1 receptor expression and the production of inflammatory mediators after exposure to histamine receptor agonists and antagonists. Results: Cultured keratinocytes constitutively expressed the H1 receptor mRNA and protein, which was not influenced by IFN-gamma, TNF-alpha, or IL-4. H1 but not H2 agonists induced calcium fluxes in keratinocytes. Treatment of keratinocytes with histamine (10 -7 to 10 -4 mol/L) or beta-histine increased the IFN-gamma-induced expression of membrane intercellular adhesion molecule 1 and MHC class I but not MHC class II molecules. Moreover, H1 stimulation promoted basal CC chemokine ligand (CCL)-5/RANTES and GM-CSF secretion and augmented IFN-gamma-induced release of the chemokines CCL2/monocyte chemoattractant protein 1, CCL5/RANTES, CCL20/macrophage inflammatory protein 3alpha, and CXC chemokine ligand 10/IFN-induced protein of 10 kd, as well as GM-CSF. Administration of the H1 antihistamine levocetirizine, but not of the H2 antihistamine cimetidine, abolished histamine-dependent expression of all of the investigated proinflammatory molecules in a dose-dependent manner (0.01-10 mumol/L). Levocetirizine at higher doses also reduced intercellular adhesion molecule 1, CCL5/RANTES, and GM-CSF release induced solely by IFN-gamma. Conclusion: Histamine exerts proinflammatory effects on keratinocytes via the H1 receptor, and these effects are efficiently inhibited by levocetirizine.

Application of Histamine Receptors H2R, H3R and H4R, but Not H1R, in Dermatology

Update on Histamine and Antihistamines

The histamine H4 receptor: from orphan to the clinic

The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets

Advances in clinical application of H1 antihistamines in the treatment of skin diseases.

Histamine receptors, agonists, and antagonists in health and disease

TRPV1 SUMOylation suppresses itch by inhibiting TRPV1 interaction with H1 receptors

The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut

Advances on Research of Function and Regulatory Mechanism of Histamine H1 Receptor

Research and Development of Histamine H1 Receptor Antagonist

ROLE OF H3 RECEPTORS IN PRIMARY AFFERENT PATHWAY OF 5-HT-INDUCED ITCH IN RATS

H1 histamine receptor mediates inflammatory responses in human keratinocytes

Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo

Studies of H4R Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Docking and MD Study of Histamine H4R Based on the Crystal Structure of H1R

A Novel Histamine Receptor:Histamine H4 Receptor

In Silico Binding Characteristics Between Human Histamine H-1 Receptor and Antagonists

Different Expression of Histamine H4 Receptor in Nasal Mucosa in Allergic Rhinitis Patients

Classification and biological distribution of histamine receptor sub-types

Progress of Histamine H3 Receptor Antagonist

Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy